Novel technologies make it possible to incorporate pharmacogenetic testing into the medical management of depression. However, previous studies indicate that there may be a subset of subjects who have concerns about genetic testing and may be psychologically vulnerable. If so, pharmacogenetic testing in depressed subjects could negatively impact their mental health and undermine treatment goals.

中文翻译：

---

难治性抑郁症精神病患者对药物遗传学检测的态度。

新技术使将药物遗传学检测纳入抑郁症的医疗管理成为可能。然而，之前的研究表明，可能有一部分受试者对基因检测有顾虑，并且可能在心理上很脆弱。如果是这样，抑郁症受试者的药物遗传学测试可能会对他们的心理健康产生负面影响并破坏治疗目标。